Evidence map›Paper›PMID 27438786›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.

Miranda Sun, Ramaswamy Ramchandran, Jiwang Chen, Qiwei Yang, J Usha Raj

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Growth factors involved in vascular remodeling in pulmonary arterial hypertension.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Miranda Sun1 Department of Pediatrics.
Ramaswamy Ramchandran1 Department of Pediatrics.
Jiwang Chen2 Section of Pulmonary, Critical Care Medicine, Sleep and Allergy, Department of Medicine, University of Illinois College of Medicine, and.
Qiwei Yang1 Department of Pediatrics.
J Usha Raj1 Department of Pediatrics.
Pediatrics and Genetics · USIllinois College · USUniversity of Illinois Chicago · US

Funding

Functional Heterogeneity of Pulmonary Arteries and VeinsR01HL075187 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAJ, J. USHA · 2003 to 2011
$3.8M
MicroRNAs in Regulation of Pulmonary Vascular Smooth Muscle Cell ProliferationR03HL110829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAJ, J. USHA · 2011 to 2012
$159k
NHLBI NIH HHS R01 HL075187NHLBI NIH HHS R03 HL110829
6 · The paper itself

Abstract

Insulin-like growth factor (IGF)-1 is a potent mitogen of vascular smooth muscle cells (SMCs), but its role in pulmonary vascular remodeling associated with pulmonary hypertension (PH) is not clear. In an earlier study, we implicated IGF-1 in the pathogenesis of hypoxia-induced PH in neonatal mice. In this study, we hypothesized that hypoxia-induced up-regulation of IGF-1 in vascular smooth muscle is directly responsible for pulmonary vascular remodeling and PH. We studied neonatal and adult mice with smooth muscle-specific deletion of IGF-1 and also used an inhibitor of IGF-1 receptor (IGF-1R), OSI-906, in neonatal mice. We found that, in neonatal mice, SMC-specific deletion of IGF-1 or IGF-1R inhibition with OSI-906 attenuated hypoxia-induced pulmonary vascular remodeling in small arteries, right ventricular hypertrophy, and right ventricular systolic pressure. Pulmonary arterial SMCs from IGF-1-deleted mice or after OSI-906 treatment exhibited reduced proliferative potential. However, in adult mice, smooth muscle-specific deletion of IGF-1 had no effect on hypoxia-induced PH. Our data suggest that vascular smooth muscle-derived IGF-1 plays a critical role in hypoxia-induced PH in neonatal mice but not in adult mice. We speculate that the IGF-1/IGF-1R axis is important in pathogenesis of PH in the developing lung and may be amenable to therapeutic manipulation in this age group.

Indexed as

AnimalsAnimals, NewbornBlood PressureCell ProliferationChronic DiseaseGene DeletionHypertension, PulmonaryHypertrophy, Right VentricularHypoxiaImidazolesInsulin-Like Growth Factor IMice, Inbred C57BLMice, KnockoutMuscle, SmoothMyocytes, Smooth MuscleOrgan Specificity3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanolImidazolesInsulin-Like Growth Factor IProto-Oncogene Proteins c-aktPyrazinesReceptor, IGF Type 1RNA, Messengerhypoxiainsulin-like growth factorneonatalpulmonary hypertensionvascular smooth muscle

Identifiers

PMID27438786
PMCPMC5248951
OpenAlexW2501807035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.